A new NIH study published in Nature, based on research by Sharon Cantor, PhD, helps scientists better understand how hereditary breast and ovarian cancer genes function in the repair of broken DNA. Members of Dr. Cantor’s lab contributed to the study.
Job Dekker, PhD, and scientists at Institut Curie in Paris and Stanford University have taken a detailed look inside the small, densely packed structure of the inactive X chromosome found in female mammals called the Barr body.
Michael Green, MD, PhD, is one of five scientific co-founders of Fulcrum Therapeutics, a new company located in Cambridge’s Kendall Square focused on discovering and developing small molecules that modulate the on/off control mechanisms that regulate genes.
GSBS student Hatem Elif Kamber Kaya was honored to have two speaking engagements at The Allied Genetics Conference, the annual national meeting of the Genetics Society of America.
Vladimir Litvak, PhD, and colleagues made a startling discovery that immune system signaling can directly affect social behavior. Published in Nature, these findings could have great implications for neurological diseases such as autism-spectrum disorders and schizophrenia.
For 20 years the Meyers Primary Care Institute—a unique partnership between UMass Medical School, Fallon Health and Reliant Medical Group—has quietly improved population health through research and education.
A long noncoding RNA (lincRNA)—called lincRNA-EPS—responsible for regulating innate immunity has been identified by a team of scientists at UMass Medical School. The findings were published in Cell. Katherine A. Fitzgerald, PhD, professor of medicine, is senior author on the study.
Shashi Kant, PhD, instructor of medicine, has received a $231,000 Scientist Development Grant from the American Heart Association to study a specific protein that could be the link between type 2 diabetes and atherosclerosis.
Peter R. Chai, MD, assistant professor of emergency medicine, discussed his research using Google Glass in the emergency department in a CNBC “The Spark” interview.
Stephen C. Miller, PhD, associate professor of biochemistry & molecular pharmacology, received a 2016 McKnight Technological Innovations in Neuroscience Award for his work overcoming barriers to imaging in the brain.